Skip to content
Recall Observatory FDA recall evidence

Drug product

Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-448-90

D-1293-2022

July 18, 2022

Class II

Product summary

Firm
Jubilant Cadista Pharmaceuticals, Inc.
Event
Event 90610
Status
Terminated
Classification
Class II
Quantity
9,600 bottles
Official record key
drug-enforcement:D-1293-2022

Official wording

Reason: Failed dissolution specifications.

Code information: Lot #: IB220023A, exp. date 08/2022

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed dissolution specifications